speb/financial-data huggingface dataset:
AGN.AS income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 0.00
AGN.AS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 688000000.00
AGN.AS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 688000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 660000000.00
AGN.AS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 676000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -15000000.00
AGN.AS income_statement (annual, 2024-12-31) — Net Interest Income: -6000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -246000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -246000000.00
AGN.AS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -6000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -63000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -1000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Net PPE: 400000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Net PPE: 400000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -31000000.00
AGN.AS income_statement (annual, 2024-12-31) — Net Policyholder Benefits And Claims: 16630000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 8612000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 8612000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 70000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 70000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 6000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 6000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 64000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 64000000.00
AGN.AS income_statement (annual, 2024-12-31) — Normalized Income: 688000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Operating Cash Flow: 762000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Operating Gains Losses: -21248000000.00
AGN.AS income_statement (annual, 2024-12-31) — Operating Revenue: 19519000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 1592499013.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 1592499013.00
AGN.AS balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 37000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 37000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 951000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 951000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Other Equity Interest: 1971000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 1971000000.00
AGN.AS income_statement (annual, 2024-12-31) — Other Gand A: 785000000.00
AGN.AS income_statement (annual, 2024-12-31) — Other Income Expense: 27000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 230000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 230000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 10527000000.00
AGN.AS income_statement (annual, 2024-12-31) — Other Operating Expenses: -158000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Other Payable: 2112000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Other Payable: 2112000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 54716000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 54716000000.00
AGN.AS income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 77000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Payables: 3493000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Payables: 3493000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 3825000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 3825000000.00
AGN.AS income_statement (annual, 2024-12-31) — Policyholder Benefits Ceded: 949000000.00
AGN.AS income_statement (annual, 2024-12-31) — Policyholder Benefits Gross: 17579000000.00
AGN.AS income_statement (annual, 2024-12-31) — Pretax Income: 660000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Purchase Of Business: -49000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -15000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -51000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Receivables: 3830000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Receivables: 3830000000.00
AGN.AS income_statement (annual, 2024-12-31) — Reconciled Depreciation: -31000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Repayment Of Debt: -946000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -925000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Retained Earnings: 4347000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 4347000000.00
AGN.AS income_statement (annual, 2024-12-31) — Salaries And Wages: 1198000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Sale Of Business: 56000000.00
AGN.AS cash_flow (annual, 2024-12-31) — Sale Of Intangibles: 0.00
AGN.AS cash_flow (annual, 2024-12-31) — Sale Of PPE: 20000000.00
AGN.AS income_statement (annual, 2024-12-31) — Selling General And Administration: 1983000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Share Issued: 1661433491.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Share Issued: 1661433491.00
AGN.AS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 9187000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 9187000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 8612000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 8612000000.00
AGN.AS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
AGN.AS income_statement (annual, 2024-12-31) — Tax Provision: -16000000.00
AGN.AS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.26
AGN.AS cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -80000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Total Assets: 327390000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Total Assets: 327390000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Total Capitalization: 13929000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 13929000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Total Debt: 4995000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Total Debt: 4995000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 9313000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 9313000000.00
AGN.AS income_statement (annual, 2024-12-31) — Total Expenses: 18862000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 318077000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 318077000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Total Tax Payable: 61000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 61000000.00
AGN.AS balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 69133114.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 69133114.00
AGN.AS balance_sheet (annual, 2024-12-31) — Treasury Stock: 398000000.00
AGN.AS balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 398000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 6853000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 241000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 3200000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 53683000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Common Stock: 241000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 9258000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 2044000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Fixed Assets Revaluation Reserve: -2909000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -3877000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 525000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 13526000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 280298000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 4455000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 4268000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 4268000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 4455000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Minimum Pension Liabilities: -969000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Minority Interest: 130000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Net Debt: 1068000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 8733000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1567298843.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 1958000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 50483000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 4083000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Share Issued: 1661433491.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 9258000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 8733000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Total Assets: 310635000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 13526000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Total Debt: 4268000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 9389000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 301246000000.00
AGN.AS balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 94333284.00
AGN.AS income_statement (annual, 2025-12-31) — +Total Revenue: 26864000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Accounts Payable: 1158000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1158000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 3472000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 3472000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 6853000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 6853000000.00
AGN.AS income_statement (annual, 2025-12-31) — Amortization: 18000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 69000000.00
AGN.AS income_statement (annual, 2025-12-31) — Basic Average Shares: 1898000000.00
AGN.AS income_statement (annual, 2025-12-31) — Basic EPS: 0.59
AGN.AS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 3469000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Capital Expenditure: -54000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 187000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 187000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Capital Stock: 229000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 229000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 2733000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2733000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 52490000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 52490000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -596000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2035000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 1010000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 435000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 95000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 95000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Change In Working Capital: 13705000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Changes In Cash: -591000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Common Stock: 229000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Common Stock: 229000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -596000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 9410000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 9410000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Common Stock Payments: -549000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 303000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 303000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Current Debt: 10000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Current Debt: 10000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 10000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 10000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 95000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 95000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: -167000000.00
AGN.AS income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 18000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 1469000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 1469000000.00
AGN.AS income_statement (annual, 2025-12-31) — Diluted Average Shares: 1898000000.00
AGN.AS income_statement (annual, 2025-12-31) — Diluted EPS: 0.59
AGN.AS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 925000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 400000000.00
AGN.AS income_statement (annual, 2025-12-31) — EBIT: 1051000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -503000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -144000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Employee Benefits: 507000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 507000000.00
AGN.AS cash_flow (annual, 2025-12-31) — End Cash Position: 2733000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Financing Cash Flow: -2035000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Fixed Assets Revaluation Reserve: -2519000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Fixed Assets Revaluation Reserve: -2519000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Free Cash Flow: 380000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -26228000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -3442000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -3442000000.00
AGN.AS income_statement (annual, 2025-12-31) — General And Administrative Expense: 1969000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Goodwill: 313000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Goodwill: 313000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 519000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 519000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Income Tax Payable: 62000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 62000000.00
AGN.AS income_statement (annual, 2025-12-31) — Interest Expense: 6000000.00
AGN.AS income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 6000000.00
AGN.AS income_statement (annual, 2025-12-31) — Interest Income: 5813000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Interest Payable: 35000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Interest Payable: 35000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Invested Capital: 12952000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 12952000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Investing Cash Flow: 1010000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Investments And Advances: 288866000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 288866000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 4204000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 4204000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Issuance Of Debt: 946000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 187000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 187000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Long Term Debt: 3532000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 3532000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3719000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3719000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 946000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1740000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 4204000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 4204000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Long Term Provisions: 97000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 97000000.00
AGN.AS income_statement (annual, 2025-12-31) — Loss Adjustment Expense: 20240000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Minimum Pension Liabilities: -966000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Minimum Pension Liabilities: -966000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Minority Interest: 85000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Minority Interest: 85000000.00
AGN.AS income_statement (annual, 2025-12-31) — Minority Interests: -3000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 659000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -549000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Net Debt: 809000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Net Debt: 809000000.00
AGN.AS income_statement (annual, 2025-12-31) — Net Income: 977000000.00
AGN.AS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 925000000.00
AGN.AS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 980000000.00
AGN.AS income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
AGN.AS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 977000000.00
AGN.AS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 977000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1045000000.00
AGN.AS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 980000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -13000000.00
AGN.AS income_statement (annual, 2025-12-31) — Net Interest Income: -6000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -794000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -794000000.00
AGN.AS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -6000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -96000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Net PPE: 336000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Net PPE: 336000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -36000000.00
AGN.AS income_statement (annual, 2025-12-31) — Net Policyholder Benefits And Claims: 20240000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 8891000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 8891000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 18000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 18000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 5000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 5000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 13000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 13000000.00
AGN.AS income_statement (annual, 2025-12-31) — Normalized Income: 977000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Operating Cash Flow: 434000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Operating Gains Losses: -26731000000.00
AGN.AS income_statement (annual, 2025-12-31) — Operating Revenue: 26864000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1512525453.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1512525453.00
AGN.AS balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 10000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 10000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 43000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 43000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Other Equity Interest: 1979000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 1979000000.00
AGN.AS income_statement (annual, 2025-12-31) — Other Gand A: 684000000.00
AGN.AS income_statement (annual, 2025-12-31) — Other Income Expense: 31000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 206000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 206000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Other Non Cash Items: 12564000000.00
AGN.AS income_statement (annual, 2025-12-31) — Other Operating Expenses: -150000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Other Payable: 1736000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Other Payable: 1736000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 49757000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 49757000000.00
AGN.AS income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 52000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Payables: 2956000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Payables: 2956000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 3259000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3259000000.00
AGN.AS income_statement (annual, 2025-12-31) — Policyholder Benefits Ceded: 1412000000.00
AGN.AS income_statement (annual, 2025-12-31) — Policyholder Benefits Gross: 21652000000.00
AGN.AS income_statement (annual, 2025-12-31) — Pretax Income: 1045000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Purchase Of Business: -97000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -13000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Purchase Of PPE: -41000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Receivables: 3472000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Receivables: 3472000000.00
AGN.AS income_statement (annual, 2025-12-31) — Reconciled Depreciation: -167000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1740000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -549000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Retained Earnings: 4238000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 4238000000.00
AGN.AS income_statement (annual, 2025-12-31) — Salaries And Wages: 1285000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Sale Of Business: 756000000.00
AGN.AS cash_flow (annual, 2025-12-31) — Sale Of Intangibles: 0.00
AGN.AS cash_flow (annual, 2025-12-31) — Sale Of PPE: 5000000.00
AGN.AS income_statement (annual, 2025-12-31) — Selling General And Administration: 1969000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Share Issued: 1581317000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Share Issued: 1581317000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Stockholders Equity: 9410000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 9410000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Tangible Book Value: 8891000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 8891000000.00
AGN.AS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AGN.AS income_statement (annual, 2025-12-31) — Tax Provision: 65000000.00
AGN.AS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.05
AGN.AS cash_flow (annual, 2025-12-31) — Taxes Refund Paid: 76000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Total Assets: 317233000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Total Assets: 317233000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Total Capitalization: 12942000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 12942000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Total Debt: 3729000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Total Debt: 3729000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 9495000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 9495000000.00
AGN.AS income_statement (annual, 2025-12-31) — Total Expenses: 22535000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 307738000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 307738000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Total Tax Payable: 62000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 62000000.00
AGN.AS balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 68990183.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 68990183.00
AGN.AS balance_sheet (annual, 2025-12-31) — Treasury Stock: 447000000.00
AGN.AS balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 447000000.00
AGN.AX cash_flow (annual, 2021-06-30) — Income Tax Paid Supplemental Data: -47.00
AGN.AX cash_flow (annual, 2021-06-30) — Receiptsfrom Customers: 145000.00
AGN.AX cash_flow (annual, 2021-06-30) — Taxes Refund Paid Direct: 47.00
AGN.AX income_statement (annual, 2022-06-30) — +Operating Expense: 4351532.00
AGN.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 671825.00
AGN.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 73925675.00
AGN.AX income_statement (annual, 2022-06-30) — Basic EPS: -0.06
AGN.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 7144195.00
AGN.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 13065033.00
AGN.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 8914457.00
AGN.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 8914457.00
AGN.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 8914457.00
AGN.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 5131935.00
AGN.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -3361673.00
AGN.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 1770262.00
AGN.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -3622453.00
AGN.AX cash_flow (annual, 2022-06-30) — Classesof Cash Receiptsfrom Operating Activities: 259098.00
AGN.AX balance_sheet (annual, 2022-06-30) — Common Stock: 13065033.00
AGN.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 8307491.00
AGN.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 5131935.00
AGN.AX balance_sheet (annual, 2022-06-30) — Current Assets: 9042400.00
AGN.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 735909.00
AGN.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 73925675.00
AGN.AX income_statement (annual, 2022-06-30) — Diluted EPS: -0.06
AGN.AX income_statement (annual, 2022-06-30) — EBIT: -4089930.00
AGN.AX income_statement (annual, 2022-06-30) — EBITDA: -4089930.00
AGN.AX cash_flow (annual, 2022-06-30) — End Cash Position: 8914457.00
AGN.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 5131935.00
AGN.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -3361673.00
AGN.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 746114.00
AGN.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 1748067.00
AGN.AX balance_sheet (annual, 2022-06-30) — Goodwill And Other Intangible Assets: 1000.00
AGN.AX income_statement (annual, 2022-06-30) — Interest Expense: 822.00
AGN.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 822.00
AGN.AX income_statement (annual, 2022-06-30) — Interest Income: 2504.00
AGN.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 2504.00
AGN.AX cash_flow (annual, 2022-06-30) — Interest Paid Direct: -822.00
AGN.AX cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 822.00
AGN.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 2504.00
AGN.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 8307491.00
AGN.AX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 5131935.00
AGN.AX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 5131935.00
AGN.AX income_statement (annual, 2022-06-30) — Net Income: -4090752.00
AGN.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -4090752.00
AGN.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -4090752.00
AGN.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -4090752.00
AGN.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -4090752.00
AGN.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -4090752.00
AGN.AX income_statement (annual, 2022-06-30) — Net Interest Income: 1682.00
AGN.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: 1682.00
AGN.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 8306491.00
AGN.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: -4089930.00
AGN.AX income_statement (annual, 2022-06-30) — Normalized Income: -4090752.00
AGN.AX income_statement (annual, 2022-06-30) — Operating Income: -4351532.00
AGN.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 86922250.00
AGN.AX cash_flow (annual, 2022-06-30) — Other Cash Receiptsfrom Operating Activities: 259098.00
AGN.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 746114.00
AGN.AX income_statement (annual, 2022-06-30) — Other Gand A: 442151.00
AGN.AX income_statement (annual, 2022-06-30) — Other Income Expense: 259098.00
AGN.AX balance_sheet (annual, 2022-06-30) — Other Intangible Assets: 1000.00
AGN.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 259098.00
AGN.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 107413.00
AGN.AX balance_sheet (annual, 2022-06-30) — Other Payable: 39184.00
AGN.AX balance_sheet (annual, 2022-06-30) — Other Receivables: 72080.00
AGN.AX balance_sheet (annual, 2022-06-30) — Payables: 711009.00
AGN.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 711009.00
AGN.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -3622453.00
AGN.AX balance_sheet (annual, 2022-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 24900.00
AGN.AX balance_sheet (annual, 2022-06-30) — Prepaid Assets: 55863.00
AGN.AX income_statement (annual, 2022-06-30) — Pretax Income: -4090752.00
AGN.AX balance_sheet (annual, 2022-06-30) — Receivables: 72080.00
AGN.AX income_statement (annual, 2022-06-30) — Research And Development: 2496052.00
AGN.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -5503656.00
AGN.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 1305916.00
AGN.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 1748067.00
AGN.AX balance_sheet (annual, 2022-06-30) — Share Issued: 86922250.00
AGN.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 8307491.00
AGN.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 8306491.00
AGN.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
AGN.AX income_statement (annual, 2022-06-30) — Tax Provision: 0.00
AGN.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
AGN.AX balance_sheet (annual, 2022-06-30) — Total Assets: 9043400.00
AGN.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 8307491.00
AGN.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 8307491.00
AGN.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 735909.00
AGN.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 1000.00
AGN.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
AGN.AX balance_sheet (annual, 2022-06-30) — Working Capital: 8306491.00
AGN.AX income_statement (annual, 2023-06-30) — +Operating Expense: 6624890.00
AGN.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 1141345.00
AGN.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 87577988.00
AGN.AX income_statement (annual, 2023-06-30) — Basic EPS: -0.06
AGN.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 8914457.00
AGN.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 16618266.00
AGN.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 9289156.00
AGN.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 9339156.00
AGN.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 9289156.00
AGN.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 3725015.00
AGN.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -50000.00
AGN.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: -3300316.00
AGN.AX cash_flow (annual, 2023-06-30) — Changes In Cash: 374699.00
AGN.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -5809284.00
AGN.AX cash_flow (annual, 2023-06-30) — Classesof Cash Receiptsfrom Operating Activities: 2449021.00
AGN.AX balance_sheet (annual, 2023-06-30) — Common Stock: 16618266.00
AGN.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 7666440.00
AGN.AX cash_flow (annual, 2023-06-30) — Common Stock Issuance: 3725015.00
AGN.AX balance_sheet (annual, 2023-06-30) — Current Assets: 9539864.00
AGN.AX balance_sheet (annual, 2023-06-30) — Current Deferred Liabilities: 659069.00
AGN.AX balance_sheet (annual, 2023-06-30) — Current Deferred Revenue: 659069.00
AGN.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 1874424.00
AGN.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 87577988.00
AGN.AX income_statement (annual, 2023-06-30) — Diluted EPS: -0.06
AGN.AX income_statement (annual, 2023-06-30) — EBIT: -4813994.00
AGN.AX income_statement (annual, 2023-06-30) — EBITDA: -4813994.00
AGN.AX cash_flow (annual, 2023-06-30) — End Cash Position: 9289156.00
AGN.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 3725015.00
AGN.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -3300316.00
AGN.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 1366874.00
AGN.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 2113462.00
AGN.AX balance_sheet (annual, 2023-06-30) — Goodwill And Other Intangible Assets: 1000.00
AGN.AX income_statement (annual, 2023-06-30) — Interest Expense: 1050.00
AGN.AX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 1050.00
AGN.AX income_statement (annual, 2023-06-30) — Interest Income: 60997.00
AGN.AX income_statement (annual, 2023-06-30) — Interest Income Non Operating: 60997.00
AGN.AX cash_flow (annual, 2023-06-30) — Interest Paid Direct: -1050.00
AGN.AX cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 1050.00
AGN.AX cash_flow (annual, 2023-06-30) — Interest Received Direct: 60997.00
AGN.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 7666440.00
AGN.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -50000.00
AGN.AX cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 3725015.00
AGN.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 3725015.00
AGN.AX income_statement (annual, 2023-06-30) — Net Income: -4815044.00
AGN.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -4815044.00
AGN.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -4815044.00
AGN.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -4815044.00
AGN.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -4815044.00
AGN.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -4815044.00
AGN.AX income_statement (annual, 2023-06-30) — Net Interest Income: 59947.00
AGN.AX cash_flow (annual, 2023-06-30) — Net Investment Purchase And Sale: -50000.00
AGN.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: 59947.00
AGN.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 7665440.00
AGN.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: -4813994.00
AGN.AX income_statement (annual, 2023-06-30) — Normalized Income: -4815044.00
AGN.AX income_statement (annual, 2023-06-30) — Operating Income: -6624890.00
AGN.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 98350822.00
AGN.AX cash_flow (annual, 2023-06-30) — Other Cash Receiptsfrom Operating Activities: 1377917.00
AGN.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 1366874.00
AGN.AX income_statement (annual, 2023-06-30) — Other Gand A: 622521.00
AGN.AX income_statement (annual, 2023-06-30) — Other Income Expense: 1749899.00
AGN.AX balance_sheet (annual, 2023-06-30) — Other Intangible Assets: 1000.00
AGN.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 1749899.00
AGN.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 203348.00
AGN.AX balance_sheet (annual, 2023-06-30) — Other Payable: 41579.00
AGN.AX balance_sheet (annual, 2023-06-30) — Other Receivables: 152362.00
AGN.AX balance_sheet (annual, 2023-06-30) — Other Short Term Investments: 50000.00
AGN.AX balance_sheet (annual, 2023-06-30) — Payables: 1182924.00
AGN.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 1182924.00
AGN.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -5809284.00
AGN.AX balance_sheet (annual, 2023-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 32431.00
AGN.AX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 48346.00
AGN.AX income_statement (annual, 2023-06-30) — Pretax Income: -4815044.00
AGN.AX cash_flow (annual, 2023-06-30) — Purchase Of Investment: -50000.00
AGN.AX cash_flow (annual, 2023-06-30) — Receiptsfrom Government Grants: 1071104.00
AGN.AX balance_sheet (annual, 2023-06-30) — Receivables: 152362.00
AGN.AX income_statement (annual, 2023-06-30) — Research And Development: 4308080.00
AGN.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -10318700.00
AGN.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 1490941.00
AGN.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 2113462.00
AGN.AX balance_sheet (annual, 2023-06-30) — Share Issued: 98350822.00
AGN.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 7666440.00
AGN.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 7665440.00
AGN.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
AGN.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
AGN.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
AGN.AX balance_sheet (annual, 2023-06-30) — Total Assets: 9540864.00
AGN.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 7666440.00
AGN.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 7666440.00
AGN.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 1874424.00
AGN.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 1000.00
AGN.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
AGN.AX balance_sheet (annual, 2023-06-30) — Working Capital: 7665440.00
AGN.AX income_statement (annual, 2024-06-30) — +Operating Expense: 8269141.00
AGN.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 1403027.00
AGN.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 103707092.00
AGN.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.05
AGN.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 9289156.00
AGN.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 28428742.00
AGN.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 15912660.00
AGN.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 15912660.00
AGN.AX balance_sheet (annual, 2024-06-30) — Cash Equivalents: 12051180.00
AGN.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 3861480.00
AGN.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 11634065.00
AGN.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: 50000.00
AGN.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -5060561.00
AGN.AX cash_flow (annual, 2024-06-30) — Changes In Cash: 6623504.00
AGN.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -7851396.00
AGN.AX cash_flow (annual, 2024-06-30) — Classesof Cash Receiptsfrom Operating Activities: 2698157.00
AGN.AX balance_sheet (annual, 2024-06-30) — Common Stock: 28428742.00
AGN.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 13950835.00
AGN.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 11634065.00
AGN.AX balance_sheet (annual, 2024-06-30) — Current Assets: 16376555.00
AGN.AX balance_sheet (annual, 2024-06-30) — Current Deferred Liabilities: 704347.00
AGN.AX balance_sheet (annual, 2024-06-30) — Current Deferred Revenue: 704347.00
AGN.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 2426720.00
AGN.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 103707092.00
AGN.AX income_statement (annual, 2024-06-30) — Diluted EPS: -0.05
AGN.AX income_statement (annual, 2024-06-30) — EBIT: -5479119.00
AGN.AX income_statement (annual, 2024-06-30) — EBITDA: -5479119.00
AGN.AX cash_flow (annual, 2024-06-30) — End Cash Position: 15912660.00
AGN.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: 11634065.00
AGN.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -5060561.00
AGN.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 1208147.00
AGN.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 2071189.00
AGN.AX balance_sheet (annual, 2024-06-30) — Goodwill And Other Intangible Assets: 1000.00
AGN.AX income_statement (annual, 2024-06-30) — Interest Expense: 369.00
AGN.AX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 369.00
AGN.AX income_statement (annual, 2024-06-30) — Interest Income: 192085.00
AGN.AX income_statement (annual, 2024-06-30) — Interest Income Non Operating: 192085.00
AGN.AX cash_flow (annual, 2024-06-30) — Interest Paid Direct: -369.00
AGN.AX cash_flow (annual, 2024-06-30) — Interest Paid Supplemental Data: 369.00
AGN.AX cash_flow (annual, 2024-06-30) — Interest Received Direct: 93047.00
AGN.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 13950835.00
AGN.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: 50000.00
AGN.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 11634065.00
AGN.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 11634065.00
AGN.AX income_statement (annual, 2024-06-30) — Net Income: -5479488.00
AGN.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -5479488.00
AGN.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -5479488.00
AGN.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -5479488.00
AGN.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -5479488.00
AGN.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -5479488.00
AGN.AX income_statement (annual, 2024-06-30) — Net Interest Income: 191716.00
AGN.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: 191716.00
AGN.AX cash_flow (annual, 2024-06-30) — Net Other Investing Changes: 50000.00
AGN.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 13949835.00
AGN.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: -5479119.00
AGN.AX income_statement (annual, 2024-06-30) — Normalized Income: -5479488.00
AGN.AX income_statement (annual, 2024-06-30) — Operating Income: -8269141.00
AGN.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 123701026.00
AGN.AX cash_flow (annual, 2024-06-30) — Other Cash Receiptsfrom Operating Activities: 2089308.00
AGN.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 1208147.00
AGN.AX income_statement (annual, 2024-06-30) — Other Gand A: 666736.00
AGN.AX income_statement (annual, 2024-06-30) — Other Income Expense: 2597937.00
AGN.AX balance_sheet (annual, 2024-06-30) — Other Intangible Assets: 1000.00
AGN.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: 2597937.00
AGN.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 181199.00
AGN.AX balance_sheet (annual, 2024-06-30) — Other Payable: 269476.00
AGN.AX balance_sheet (annual, 2024-06-30) — Other Receivables: 372076.00
AGN.AX balance_sheet (annual, 2024-06-30) — Payables: 1672503.00
AGN.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 1672503.00
AGN.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -7851396.00
AGN.AX balance_sheet (annual, 2024-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 49870.00
AGN.AX balance_sheet (annual, 2024-06-30) — Prepaid Assets: 91819.00
AGN.AX income_statement (annual, 2024-06-30) — Pretax Income: -5479488.00
AGN.AX cash_flow (annual, 2024-06-30) — Receiptsfrom Government Grants: 608849.00
AGN.AX balance_sheet (annual, 2024-06-30) — Receivables: 372076.00
AGN.AX income_statement (annual, 2024-06-30) — Research And Development: 6016753.00
AGN.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -15686054.00
AGN.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 1404453.00
AGN.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 2071189.00
AGN.AX balance_sheet (annual, 2024-06-30) — Share Issued: 123701026.00